BioCardia, Inc.
BCDA
$2.10
-$0.17-7.49%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 58.00K | 71.00K | 428.00K | 468.00K | 477.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 58.00K | 71.00K | 428.00K | 468.00K | 477.00K |
| Cost of Revenue | 1.42M | 4.13M | 5.07M | 6.58M | 7.73M |
| Gross Profit | -1.36M | -4.06M | -4.64M | -6.12M | -7.25M |
| SG&A Expenses | 3.67M | 3.71M | 3.97M | 4.29M | 4.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.06M | 7.84M | 9.03M | 10.88M | 12.12M |
| Operating Income | -8.00M | -7.76M | -8.61M | -10.41M | -11.64M |
| Income Before Tax | -7.95M | -7.72M | -8.56M | -10.34M | -11.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.95 | -7.72 | -8.56 | -10.34 | -11.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.95M | -7.72M | -8.56M | -10.34M | -11.57M |
| EBIT | -8.00M | -7.76M | -8.61M | -10.41M | -11.64M |
| EBITDA | -7.93M | -7.69M | -8.53M | -10.33M | -11.56M |
| EPS Basic | -3.34 | -4.22 | -5.40 | -7.04 | -8.29 |
| Normalized Basic EPS | -2.09 | -2.64 | -3.37 | -4.40 | -5.18 |
| EPS Diluted | -3.85 | -4.22 | -5.40 | -7.04 | -8.29 |
| Normalized Diluted EPS | -2.09 | -2.64 | -3.37 | -4.40 | -5.18 |
| Average Basic Shares Outstanding | 10.97M | 7.88M | 6.50M | 5.98M | 5.65M |
| Average Diluted Shares Outstanding | 10.97M | 7.88M | 6.50M | 5.98M | 5.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
